TY - JOUR AU - Fitzmaurice, C. AU - Allen, C. AU - Barber, R. M. AU - Barregard, L. AU - Bhutta, Z. A. AU - Brenner, H. AU - Dicker, D. J. AU - Chimed-Orchir, O. AU - Dandona, R. PY - 2017 DA - 2017// TI - Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study JO - JAMA Oncol VL - 3 UR - https://doi.org/10.1001/jamaoncol.2016.5688 DO - 10.1001/jamaoncol.2016.5688 ID - Fitzmaurice2017 ER - TY - JOUR AU - Siegel, R. L. AU - Miller, K. D. AU - Jemal, A. PY - 2017 DA - 2017// TI - Cancer statistics, 2017 JO - CA Cancer J Clin VL - 67 UR - https://doi.org/10.3322/caac.21387 DO - 10.3322/caac.21387 ID - Siegel2017 ER - TY - JOUR AU - Rahib, L. AU - Smith, B. D. AU - Aizenberg, R. AU - Rosenzweig, A. B. AU - Fleshman, J. M. AU - Matrisian, L. M. PY - 2014 DA - 2014// TI - Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States JO - Cancer Res VL - 74 UR - https://doi.org/10.1158/0008-5472.CAN-14-0155 DO - 10.1158/0008-5472.CAN-14-0155 ID - Rahib2014 ER - TY - JOUR AU - Jeon, S. M. AU - Kwon, J. W. AU - Choi, S. H. AU - Park, H. Y. PY - 2019 DA - 2019// TI - Economic burden of lung cancer: a retrospective cohort study in South Korea, 2002-2015 JO - PLoS One VL - 14 UR - https://doi.org/10.1371/journal.pone.0212878 DO - 10.1371/journal.pone.0212878 ID - Jeon2019 ER - TY - JOUR AU - Yang, S. C. AU - Lai, W. W. AU - Su, W. C. AU - Wu, S. Y. AU - Chen, H. H. AU - Wu, Y. L. AU - Hung, M. C. AU - Wang, J. D. PY - 2013 DA - 2013// TI - Estimating the lifelong health impact and financial burdens of different types of lung cancer JO - BMC Cancer VL - 13 UR - https://doi.org/10.1186/1471-2407-13-579 DO - 10.1186/1471-2407-13-579 ID - Yang2013 ER - TY - JOUR AU - Hwang, J. S. AU - Wang, J. D. PY - 1999 DA - 1999// TI - Monte Carlo estimation of extrapolation of quality-adjusted survival for follow-up studies JO - Stat Med VL - 18 UR - https://doi.org/3.0.CO;2-D DO - 3.0.CO;2-D ID - Hwang1999 ER - TY - JOUR AU - Hwang, J. S. AU - Hu, T. H. AU - Lee, L. J. AU - Wang, J. D. PY - 2017 DA - 2017// TI - Estimating lifetime medical costs from censored claims data JO - Health Econ VL - 26 UR - https://doi.org/10.1002/hec.3512 DO - 10.1002/hec.3512 ID - Hwang2017 ER - TY - JOUR AU - Franklin, C. AU - Livingstone, E. AU - Roesch, A. AU - Schilling, B. AU - Schadendorf, D. PY - 2017 DA - 2017// TI - Immunotherapy in melanoma: recent advances and future directions JO - Eur J Surg Oncol VL - 43 UR - https://doi.org/10.1016/j.ejso.2016.07.145 DO - 10.1016/j.ejso.2016.07.145 ID - Franklin2017 ER - TY - JOUR AU - Rubio-Rodriguez, D. AU - Diego Blanco, S. AU - Perez, M. AU - Rubio-Terres, C. PY - 2017 DA - 2017// TI - Cost-effectiveness of drug treatments for advanced melanoma: a systematic literature review JO - PharmacoEconomics VL - 35 UR - https://doi.org/10.1007/s40273-017-0517-1 DO - 10.1007/s40273-017-0517-1 ID - Rubio-Rodriguez2017 ER - TY - JOUR AU - Lin, D. Y. AU - Feuer, E. J. AU - Etzioni, R. AU - Wax, Y. PY - 1997 DA - 1997// TI - Estimating medical costs from incomplete follow-up data JO - Biometrics VL - 53 UR - https://doi.org/10.2307/2533947 DO - 10.2307/2533947 ID - Lin1997 ER - TY - JOUR AU - Etzioni, R. AU - Urban, N. AU - Baker, M. PY - 1996 DA - 1996// TI - Estimating the costs attributable to a disease with application to ovarian cancer JO - J Clin Epidemiol VL - 49 UR - https://doi.org/10.1016/0895-4356(96)89259-6 DO - 10.1016/0895-4356(96)89259-6 ID - Etzioni1996 ER - TY - JOUR AU - Pinsky, P. F. AU - Church, T. R. AU - Izmirlian, G. AU - Kramer, B. S. PY - 2013 DA - 2013// TI - The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology JO - Cancer VL - 119 UR - https://doi.org/10.1002/cncr.28326 DO - 10.1002/cncr.28326 ID - Pinsky2013 ER - TY - JOUR PY - 2019 DA - 2019// TI - Lung cancer incidence and mortality with extended follow-up in the National Lung Screening Trial JO - J Thorac Oncol VL - 14 UR - https://doi.org/10.1016/j.jtho.2019.05.044 DO - 10.1016/j.jtho.2019.05.044 ID - ref13 ER - TY - JOUR AU - Chen, P. C. AU - Lee, J. C. AU - Wang, J. D. PY - 2015 DA - 2015// TI - Estimation of life-year loss and lifetime costs for different stages of colon adenocarcinoma in Taiwan JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0133755 DO - 10.1371/journal.pone.0133755 ID - Chen2015 ER - TY - JOUR AU - Gong, Y. H. AU - Yoon, S. J. AU - Jo, M. W. AU - Kim, A. AU - Kim, Y. A. AU - Yoon, J. AU - Seo, H. AU - Kim, D. PY - 2016 DA - 2016// TI - The burden of cancer in Korea during 2012: findings from a prevalence-based approach JO - J Korean Med Sci VL - 31 UR - https://doi.org/10.3346/jkms.2016.31.S2.S168 DO - 10.3346/jkms.2016.31.S2.S168 ID - Gong2016 ER - TY - JOUR AU - Carter, A. J. AU - Nguyen, C. N. PY - 2012 DA - 2012// TI - A comparison of cancer burden and research spending reveals discrepancies in the distribution of research funding JO - BMC Public Health VL - 12 UR - https://doi.org/10.1186/1471-2458-12-526 DO - 10.1186/1471-2458-12-526 ID - Carter2012 ER - TY - JOUR AU - Burnet, N. G. AU - Jefferies, S. J. AU - Benson, R. J. AU - Hunt, D. P. AU - Treasure, F. P. PY - 2005 DA - 2005// TI - Years of life lost (YLL) from cancer is an important measure of population burden--and should be considered when allocating research funds JO - Br J Cancer VL - 92 UR - https://doi.org/10.1038/sj.bjc.6602321 DO - 10.1038/sj.bjc.6602321 ID - Burnet2005 ER - TY - JOUR AU - Knight, K. AU - Oliphant, R. AU - Maxwell, F. AU - McKenzie, C. AU - McCann, M. AU - Hammill, R. AU - Sharma, P. AU - Macdonald, A. PY - 2016 DA - 2016// TI - Colorectal cancer in the elderly and the influence of lead time bias: better survival does not equate with improved life expectancy JO - Int J Color Dis VL - 31 UR - https://doi.org/10.1007/s00384-015-2496-z DO - 10.1007/s00384-015-2496-z ID - Knight2016 ER - TY - STD TI - Murray CJ, Lopez AD, Macdonald A, Stein C: Global programme on evidence for health policy discussion paper no. 36 World Health Organization., November 2001 (revised) The Global Burden of DIsease 2000 Project: aims, methods, and data sources. https://www.who.int/healthinfo/paper36.pdf. Accessed in 1 May 2019. UR - https://www.who.int/healthinfo/paper36.pdf ID - ref19 ER - TY - JOUR AU - Gildea, T. R. AU - DaCosta, B. S. AU - Hogarth, D. K. AU - Wilson, D. S. AU - Quinn, C. C. PY - 2017 DA - 2017// TI - A retrospective analysis of delays in the diagnosis of lung cancer and associated costs JO - Clinicoecon Outcomes Res VL - 9 UR - https://doi.org/10.2147/CEOR.S132259 DO - 10.2147/CEOR.S132259 ID - Gildea2017 ER - TY - JOUR AU - Malhotra, J. AU - Jabbour, S. K. AU - Aisner, J. PY - 2017 DA - 2017// TI - Current state of immunotherapy for non-small cell lung cancer JO - Transl Lung Cancer Res VL - 6 UR - https://doi.org/10.21037/tlcr.2017.03.01 DO - 10.21037/tlcr.2017.03.01 ID - Malhotra2017 ER - TY - JOUR AU - Russell, L. B. AU - Gold, M. R. AU - Siegel, J. E. AU - Daniels, N. AU - Weinstein, M. C. PY - 1996 DA - 1996// TI - The role of cost-effectiveness analysis in health and medicine. Panel on cost-effectiveness in health and medicine JO - JAMA VL - 276 UR - https://doi.org/10.1001/jama.1996.03540140060028 DO - 10.1001/jama.1996.03540140060028 ID - Russell1996 ER - TY - JOUR AU - Guirgis, H. M. PY - 2018 DA - 2018// TI - The impact of PD-L1 on survival and value of the immune check point inhibitors in non-small-cell lung cancer; proposal, policies and perspective JO - J Immunother Cancer VL - 6 UR - https://doi.org/10.1186/s40425-018-0320-3 DO - 10.1186/s40425-018-0320-3 ID - Guirgis2018 ER - TY - JOUR AU - Schwarzkopf, L. AU - Wacker, M. AU - Holle, R. AU - Leidl, R. AU - Gunster, C. AU - Adler, J. B. AU - Huber, R. M. PY - 2015 DA - 2015// TI - Cost-components of lung cancer care within the first three years after initial diagnosis in context of different treatment regimens JO - Lung Cancer VL - 90 UR - https://doi.org/10.1016/j.lungcan.2015.09.005 DO - 10.1016/j.lungcan.2015.09.005 ID - Schwarzkopf2015 ER - TY - JOUR AU - Vera-Llonch, M. AU - Weycker, D. AU - Glass, A. AU - Gao, S. AU - Borker, R. AU - Barber, B. AU - Oster, G. PY - 2011 DA - 2011// TI - Healthcare costs in patients with metastatic lung cancer receiving chemotherapy JO - BMC Health Serv Res VL - 11 UR - https://doi.org/10.1186/1472-6963-11-305 DO - 10.1186/1472-6963-11-305 ID - Vera-Llonch2011 ER - TY - JOUR AU - Park, J. Y. AU - Jang, S. H. PY - 2016 DA - 2016// TI - Epidemiology of lung cancer in Korea: recent trends JO - Tuberc Respir Dis (Seoul) VL - 79 UR - https://doi.org/10.4046/trd.2016.79.2.58 DO - 10.4046/trd.2016.79.2.58 ID - Park2016 ER - TY - JOUR AU - Enstone, A. AU - Greaney, M. AU - Povsic, M. AU - Wyn, R. AU - Penrod, J. R. AU - Yuan, Y. PY - 2018 DA - 2018// TI - The economic burden of small cell lung cancer: a systematic review of the literature JO - Pharmacoecon Open VL - 2 UR - https://doi.org/10.1007/s41669-017-0045-0 DO - 10.1007/s41669-017-0045-0 ID - Enstone2018 ER - TY - JOUR AU - Mariotto, A. B. AU - Yabroff, K. R. AU - Shao, Y. AU - Feuer, E. J. AU - Brown, M. L. PY - 2011 DA - 2011// TI - Projections of the cost of cancer care in the United States: 2010-2020 JO - J Natl Cancer Inst VL - 103 UR - https://doi.org/10.1093/jnci/djq495 DO - 10.1093/jnci/djq495 ID - Mariotto2011 ER -